Skip to Main Content

Author Details

Arun J Sanyal
Virginia Commonwealth University
1989
716
131
PMIDPaper TitleJournal TitlePublished Year
37364816A multisociety Delphi consensus statement on new fatty liver disease nomenclature.Ann Hepatol2024
37961761Cholestenoic acid as endogenous epigenetic regulator decreases hepatocyte lipid accumulation in vitro and in vivo.Am J Physiol Gastrointest Liver Physiol2024
38061448NIS2+<sup>TM</sup> as a screening tool to optimize patient selection in metabolic dysfunction-associated steatohepatitis clinical trials.J Hepatol2024
37789057Digital pathology for nonalcoholic steatohepatitis assessment.Nat Rev Gastroenterol Hepatol2024
37786277Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis.Aliment Pharmacol Ther2024
37505221Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).Hepatology2024
37879461Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions.J Hepatol2024
37877759Liver biopsy for assessment of suspected drug-induced liver injury in metabolic dysfunction-associated steatohepatitis clinical trials: Expert consensus from the Liver Forum.Aliment Pharmacol Ther2024
37061109Cenicriviroc Lacked Efficacy to Treat Liver Fibrosis in Nonalcoholic Steatohepatitis: AURORA Phase III Randomized Study.Clin Gastroenterol Hepatol2024
37088458Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study.Clin Gastroenterol Hepatol2024
37088457Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b Study.Clin Gastroenterol Hepatol2024
37146168Reduced metabolic flexibility is a predictor of weight gain among liver transplant recipients.Liver Transpl2024
34801743Outcomes of Nonalcoholic Steatohepatitis After Liver Transplantation: An Updated Meta-Analysis and Systematic Review.Clin Gastroenterol Hepatol2023
37806314Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial.Lancet Gastroenterol Hepatol2023
37556372NIS2+â¿¢, an effective blood-based test for the diagnosis of at-risk nonalcoholic steatohepatitis in adults 65 years and older.Hepatol Commun2023
37517454Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis.J Hepatol2023
37886204Foregut bypass <i>vs.</i> restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals.Hepatobiliary Surg Nutr2023
37834859Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective.J Clin Med2023
37693255NAFLD: Diagnostics and New Nomenclature.J Clin Exp Hepatol2023
37542503AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review.Gastroenterology2023
37541108Neutrophils exacerbate acetaminophen-induced liver injury by producing cytotoxic interferon-γ.Int Immunopharmacol2023
37932258A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis.Nat Commun2023
37499101Editorial: Feeling better about NASH-Authors' reply.Aliment Pharmacol Ther2023
37679433Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis.Nat Med2023
37537225The crosstalking immune cells network creates a collective function beyond the function of each cellular constituent during the progression of hepatocellular carcinoma.Sci Rep2023
37815451Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE Consortium.Radiology2023
37675229Fibrosis-4 index is associated with the risk of hepatocellular carcinoma in patients with cirrhosis and nonalcoholic steatohepatitis.Front Oncol2023
35697267Artificial Intelligence Improves Pathologist Agreement for Fibrosis Scores in Nonalcoholic Steatohepatitis Patients.Clin Gastroenterol Hepatol2023
35750249Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-controlled Trials.Clin Gastroenterol Hepatol2023
37024202Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis.Clin Liver Dis2023
37450086Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis.J Patient Rep Outcomes2023
37013924The future of hepatology.Hepatology2023
37143199The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome.Kidney3602023
37440949Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD - An Umbrella Overview of Systematic Review of Meta-Analysis.J Clin Exp Hepatol2023
37307997Natural history of NASH cirrhosis in liver transplant waitlist registrants.J Hepatol2023
37008387Second-Harmonic Generated Quantifiable Fibrosis Parameters Provide Signatures for Disease Progression and Regression in Nonalcoholic Fatty Liver Disease.Clin Pathol2023
37302579Reply to: "Agile scores are a good predictor of liver-related events in patients with NAFLD".J Hepatol2023
37001695A proposal from the liver forum for the management of comorbidities in non-alcoholic steatohepatitis therapeutic trials.J Hepatol2023
37364790A multisociety Delphi consensus statement on new fatty liver disease nomenclature.J Hepatol2023
37363821A multisociety Delphi consensus statement on new fatty liver disease nomenclature.Hepatology2023
37328931Improved health-related quality of life with semaglutide in people with non-alcoholic steatohepatitis: A randomised trial.Aliment Pharmacol Ther2023
37356033Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH.N Engl J Med2023
37224923NIS2+⿢, an optimisation of the blood-based biomarker NIS4® technology for the detection of at-risk NASH: A prospective derivation and validation study.J Hepatol2023
37162870AI-based histologic scoring enables automated and reproducible assessment of enrollment criteria and endpoints in NASH clinical trials.medRxiv2023
37162151Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study.Hepatology2023
37127100Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study.Gastroenterology2023
37062495Noninvasive Assessment of Liver Fibrosis in NAFLD.Clin Gastroenterol Hepatol2023
36724127The nonalcoholic steatohepatitis extended hepatocyte ballooning score: histologic classification and clinical significance.Hepatol Commun2023
36750244Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis.Gut2023
36848979Terlipressin Treatment Is Associated With Reversal of Hepatorenal Syndrome in Patients With Alcoholic Hepatitis.Clin Gastroenterol Hepatol2023
  • 1 - 50 of 716

Recommended Authors

Min Kyu Kang
Yeungnam University College of Medicine
Career Start Year 2018
Number of shared co-authors 0
Zhengtao Liu
Shulan International Medical College, Zhejiang Shuren University
Career Start Year 2012
Number of shared co-authors 0
Anouar Teriaky
Western University
Career Start Year 2011
Number of shared co-authors 1
Dan-Qin Sun
The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University
Career Start Year 2010
Number of shared co-authors 0
Joseph J Larson
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2009
Number of shared co-authors 1
Neil Rajoriya
Queen Elizabeth Hospital Birmingham
Career Start Year 2009
Number of shared co-authors 1
Saleh A Alqahtani
King Faisal Specialist Hospital & Research Centre
Career Start Year 2007
Number of shared co-authors 5
George F Mells
University of Cambridge
Career Start Year 2006
Number of shared co-authors 2
Jung Gil Park
Yeungnam University Hospital
Career Start Year 2006
Number of shared co-authors 0
Mayur Brahmania
Cumming School of Medicine
Career Start Year 2004
Number of shared co-authors 2
Ana Lleo
Humanitas University
Career Start Year 2003
Number of shared co-authors 2
Andrew Scanga
Vanderbilt University Medical Center
Career Start Year 2003
Number of shared co-authors 1
Byung Seok Kim
Catholic University of Daegu School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Won Young Tak
Kyungpook National University
Career Start Year 2001
Number of shared co-authors 3
Curtis K Argo
University of Virginia
Career Start Year 2000
Number of shared co-authors 1
Richard Gilroy
Intermountain Medical Center
Career Start Year 2000
Number of shared co-authors 2
Ali Zarrinpar
College of Medicine, University of Florida
Career Start Year 1999
Number of shared co-authors 0
Jayant A Talwalkar
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 3
Hye Won Lee
Yonsei University College of Medicine, Severance Hospital
Career Start Year 1998
Number of shared co-authors 0
Fedja A Rochling
University of Nebraska Medical Center
Career Start Year 1997
Number of shared co-authors 1
Konstantinos N Lazaridis
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 4
Pietro Invernizzi
Center for Autoimmune Liver Diseases, University of Milano-Bicocca
Career Start Year 1996
Number of shared co-authors 2
Peter St??rkel
Cliniques Universitaires Saint-Luc (CUSL)
Career Start Year 1996
Number of shared co-authors 9
Theo Heller
National Institute of Diabetes and Digestive and Kidney Diseases
Career Start Year 1996
Number of shared co-authors 4
Mark Puder
Boston Children's Hospital, Harvard Medical School
Career Start Year 1993
Number of shared co-authors 0
Christine M Hunt
Duke University Medical Center and Durham Veterans Affairs Health Care System
Career Start Year 1990
Number of shared co-authors 4
Grace L Su
University of Washington
Career Start Year 1989
Number of shared co-authors 1
Yoshiyuki Takei
Mie University
Career Start Year 1988
Number of shared co-authors 7
Paul J Pockros
Scripps Clinic and Scripps Translational Science Institute
Career Start Year 1982
Number of shared co-authors 5
Diana Barb
University of Florida
Career Start Year 1982
Number of shared co-authors 2

Collaborators

Rohit Loomba
Co-authored papers 67
Stephen A Harrison
Pinnacle Clinical Research Center
Co-authored papers 52
Zachary Goodman
Center for Liver Diseases, Inova Fairfax Hospital
Co-authored papers 26
Jaime Bosch
University Clinic for Visceral Surgery and Medicine, Bern University
Co-authored papers 9
Daniel G Maluf
University of Maryland School of Medicine
Co-authored papers 7
Frank Tacke
Charite-Universitatsmedizin Berlin
Co-authored papers 7
Miriam B Vos
Emory University and Children's Healthcare of Atlanta
Co-authored papers 6
Raymond T Chung
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 5
Chirag R Parikh
Johns Hopkins University School of Medicine
Co-authored papers 4
Michael Roden
Co-authored papers 4
Mikhail G Dozmorov
Virginia Commonwealth University
Co-authored papers 4
Ekaterina Smirnova
Institut de Genetique et de Biologie Moleculaire et Cellulaire
Co-authored papers 4
Gopinath M Subramanian
John Hunter Children's Hospital
Co-authored papers 4
Ivan Rusyn
Co-authored papers 3
Philip J Rosenthal
University of California at San Francisco
Co-authored papers 3
Michael P Curry
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 3
Gideon M Hirschfield
University of Toronto
Co-authored papers 3
Chris Gennings
Co-authored papers 3
Rohit Kohli
Children's Hospital Los Angeles
Co-authored papers 2
Alexei A Podtelezhnikov
Genetics and Pharmacogenomics, Merck & Co., Inc.
Co-authored papers 2
Davide Povero
Mayo Clinic
Co-authored papers 2
Wenhua Ren
University of Colorado Denver
Co-authored papers 2
Akiko Eguchi
Mie University Graduate School of Medicine
Co-authored papers 2
Thoetchai Peeraphatdit
University of Nebraska Medical Center
Co-authored papers 2
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 2
Drew Moghanaki
University of California Los Angeles
Co-authored papers 2
Anthony Gamst
University of California San Diego
Co-authored papers 2
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 2
Ariel E Feldstein
University of California San Diego
Co-authored papers 2
Thomas J Urban
Eshelman School of Pharmacy, University of North Carolina
Co-authored papers 2
Release 1.2